The House of Lords, the upper house of the UK parliament, has voted toallow the further limited use of human embryos for stem cell research. The free vote, to extend the provisions of the 1990 Human Fertility and Embryology Act, follows a similar vote in the lower house, the House of Commons, last December.
The vote was welcomed by the BioIndustry Association, which said the Act "now provides excellent and balanced regulation in this important area of research where the UK is at the forefront of international work."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze